Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Paracetamol + phenylephrine is a fixed-dose combination of two small molecule drugs commonly used for the symptomatic relief of colds and influenza. Paracetamol (also known as acetaminophen) acts as an analgesic and antipyretic, reducing pain (such as headache, sore throat, muscle aches) and fever. Phenylephrine is a sympathomimetic amine that acts as a nasal decongestant by constricting blood vessels in the nasal passages, thereby reducing swelling and congestion. This combination does not treat the underlying cause of infection but provides temporary relief from symptoms such as headache, body aches, feverishness, sore throat pain, sinus congestion, and blocked nose[1][2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Paracetamol + phenylephrine.